Home

malto Virus medaglia credo trial matrice Diligenza Obsoleto

Trial Scorecard: CREDO-Kyoto
Trial Scorecard: CREDO-Kyoto

Antiplatelet / Anticoagulant Therapy Evidence and Guidelines - ppt download
Antiplatelet / Anticoagulant Therapy Evidence and Guidelines - ppt download

Antiplatelet Therapy for the Secondary Prevention of Acute Coronary Syndrome
Antiplatelet Therapy for the Secondary Prevention of Acute Coronary Syndrome

SummitMD
SummitMD

Patients With Prior Myocardial Infarction, Stroke, or Symptomatic  Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect

Pharmacology in Acute Coronary Syndromes: Anti-platelet Agents Tim  Kinnaird, University Hospital Wales, Cardiff and Vale NHS Trust. - ppt  download
Pharmacology in Acute Coronary Syndromes: Anti-platelet Agents Tim Kinnaird, University Hospital Wales, Cardiff and Vale NHS Trust. - ppt download

Clopidogrel Landmark Trials | Download Table
Clopidogrel Landmark Trials | Download Table

Patients With Prior Myocardial Infarction, Stroke, or Symptomatic  Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial - ScienceDirect

The Emerging Role of the Platelet in the Progression and Management of  Atherothrombotic Disease
The Emerging Role of the Platelet in the Progression and Management of Atherothrombotic Disease

Interventional Cardiology Board Review ppt download
Interventional Cardiology Board Review ppt download

Review on trials of clopidogrel
Review on trials of clopidogrel

Aspirin+and+vascular
Aspirin+and+vascular

Effect of Addition of Clopidogrel to Aspirin on Mortality | Stroke
Effect of Addition of Clopidogrel to Aspirin on Mortality | Stroke

Application of the Academic Research Consortium High Bleeding Risk Criteria  in an All-Comers Registry of Percutaneous Coronary Intervention |  Circulation: Cardiovascular Interventions
Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions

C.R.E.D.O. C lopidogrel for the R eduction of E vents D uring O bservation  Multicenter Multinational (USA, Canada) Prospective Randomized Double  Blind. - ppt download
C.R.E.D.O. C lopidogrel for the R eduction of E vents D uring O bservation Multicenter Multinational (USA, Canada) Prospective Randomized Double Blind. - ppt download

AHAACC Guidelines for Secondary Prevention for Patients with
AHAACC Guidelines for Secondary Prevention for Patients with

Triple therapy: A review of antithrombotic treatment for patients with  atrial fibrillation undergoing percutaneous coronary intervention - Journal  of Cardiology
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology

Clopidogrel in CREDO after one year - UpToDate
Clopidogrel in CREDO after one year - UpToDate

Aspirin+and+vascular
Aspirin+and+vascular

Meta-Analysis of the Efficacy and Safety of Clopidogrel Plus Aspirin as  Compared to Antiplatelet Monotherapy for the Prevention
Meta-Analysis of the Efficacy and Safety of Clopidogrel Plus Aspirin as Compared to Antiplatelet Monotherapy for the Prevention

Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian  REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study -  Clinical Therapeutics
Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study - Clinical Therapeutics

8 European countries, 48 centres Stent implantation Double-blind  randomisation n = 1005 Clopidogrel 300mg od Aspirin 325mg od Clopidogrel  75mg od Aspirin. - ppt download
8 European countries, 48 centres Stent implantation Double-blind randomisation n = 1005 Clopidogrel 300mg od Aspirin 325mg od Clopidogrel 75mg od Aspirin. - ppt download

Setting the Stage: Achieving Acceptance for TAVR in All Patients With  Severe AS | tctmd.com
Setting the Stage: Achieving Acceptance for TAVR in All Patients With Severe AS | tctmd.com

Figure 1 from Interpreting the CHARISMA study. What is the role of dual  antiplatelet therapy with clopidogrel and aspirin? | Semantic Scholar
Figure 1 from Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin? | Semantic Scholar

PPT - Early And Long Term Treatment With Clopidogrel In Coronary Artery  Disease PowerPoint Presentation - ID:475326
PPT - Early And Long Term Treatment With Clopidogrel In Coronary Artery Disease PowerPoint Presentation - ID:475326

The Emerging Role of the Platelet in the Progression and Management of  Atherothrombotic Disease
The Emerging Role of the Platelet in the Progression and Management of Atherothrombotic Disease